When was Cygnus Technologies founded?

Cygnus Technologies was founded in 2003.

Where is Cygnus Technologies located?

Cygnus Technologies is headquartered in Southport, United States.

How many employees does Cygnus Technologies have?

As of Dec 31, 2022, Cygnus Technologies has 28 employees, reflecting a 17% year-over-year growth in headcount.

Is Cygnus Technologies a funded company?

Cygnus Technologies is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Cygnus Technologies rank among its competitors?

Cygnus Technologies ranks 21st amongst 935 active competitors, of which 75 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was BioLamina, which secured $23.6M in Apr, 2026.

Who are the top competitors of Cygnus Technologies?

Cygnus Technologies' top competitors include Abcam, Sino Biological and Enzo. Among them, BioLamina secured the most recent funding round in April, 2026.

Cygnus Technologies - 2026 Company Profile & Competitors

Company Details

Cygnus Technologies focuses on specialized analytical products to the pharmaceutical and biotechnology industry for use in process development and quality control. The product portfolio of the company includes ELISA Kits, DNA detection, and Western Blot kits, Antibodies, Immunogenicity Analysis, Antigen concentrates, and Immunoassay reagents. Additionally, the company also offers custom development services in antibody production, assay development, and bioprocess.

Website: www.cygnustechnologies.com/
Social
Email ID: *****@cygnustechnologies.com
Part Of

Key Metrics

Founded Year

2003

Location

Southport, United States

Stage

Acquired

Ranked

21^st among 935 active competitors

Employee Count

28 as on Dec 31, 2022

Similar Companies

Abcam & 1053 more

Exit Details

Acquired by Maravai Life Sciences (Oct 20, 2016)

View Cygnus Technologies' full profile

Cygnus Technologies is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
CYGNUS TECHNOLOGIES LLC CIN: 32091450679 , United States, Active		-	-	-
CYGNUS TECHNOLOGIES, INC. CIN: 611442121 , United States, Active	Dec 31, 1999	-	28 (As on Dec 31, 2018)	-
Cygnus Go CIN: 48503024734 , Latvia, Deadpooled	Mar 24, 2015	$498 (As on Dec 31, 2016)	1 (As on Dec 31, 2019)	-

Cygnus Technologies got acquired by Maravai Life Sciences on Oct 20, 2016.

Click here to take a look at Cygnus Technologies's acquisition in detail

Cygnus Technologies has not raised any funding rounds yet.

Cygnus Technologies' employee count trend

Cygnus Technologies has 28 employees as of Dec 22. The total employee count is 17.0% more than what it was in Dec 21. Here is Cygnus Technologies's employee count trend over the years:

Employee count trend for Cygnus Technologies

Uncover Cygnus Technologies' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cygnus Technologies include Abcam, Sino Biological and Enzo. Here is the list of Top 10 competitors of Cygnus Technologies, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Abcam 1998, Cambridge (United Kingdom), Acquired	Developer of biological reagents for life science research	$78.8M	Juno Investment Partners, Martlet Capital ... & 2 others	75/100
2nd	Sino Biological 2007, Beijing (China), Series A	Provider of reagents,and kits for clinical research	$29.4M	Qiming Venture Partners, CTS Capital & 1 others	67/100
3rd	Enzo 1976, Farmingdale (United States), Acquired	Life science products and services for research, drug discovery, and manufacturing	$7M	-	67/100
4th	Meridian Bioscience 1976, Ohio (United States), Acquired	Molecular diagnostic device and kits	-	JobsOhio, NIH	65/100
5th	Devyser 2004, Stockholm (Sweden), Public	Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders	$15.5M	Swedbank Robur, Fjarde AP-fonden & 1 others	61/100
6th	Miltenyi Biotec 1989, Bergisch Gladbach (Germany), Funding Raised	Develops tools and products for research and clinical application	-	Europa, HHS	59/100
7th	Stem Cell Technologies 1993, Vancouver (Canada), Series A	Developer of cell culture media and ancillary reagents for life science research	$11.9M	BDC, National Research Council Canada & 1 others	58/100
8th	BioLamina 2008, Sundbyberg (Sweden), Series B	Cell culture reagents for stem cell research	$18.2M	Lauxera Capital Partners, Bure Equity & 5 others	56/100
9th	BioIVT 1981, Westbury (United States), Acquired	Provider of in vitro diagnostic products and assay services	-	Thompson Street Capital Partners, Arsenal Capital Partners ... & 4 others	56/100
10th	GenScript 2002, Piscataway (United States), Public	Provider of reagents and instruments for life sciences research	$15M	Kleiner Perkins, Vermögensclub & 1 others	55/100
21st	Cygnus Technologies 2003, Southport (United States), Acquired	Manufacturer of analytical products for life science	-	-	51/100